Position in TVTX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$5,339,060
+$3,107,958 QoQ
Shares Held
93,981
+25.1% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#6
of 48 holders
Holding Since
Dec 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. TVTX ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
315,335 | $17,680,833 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
62,523 | $8,298,677 | |
| 3 | CGON |
CG Oncology, Inc.
|
89,218 | $6,338,938 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
97,610 | $5,891,739 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
61,014 | $5,806,702 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
55,281 | $5,388,791 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
This page
|
93,981 | $5,339,060 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
110,388 | $5,192,651 |
All Filings in TVTX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,339,060 | 93,981 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $2,231,102 | 75,096 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $2,799,379 | 73,263 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,129,107 | 47,243 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $709,630 | 47,948 | Shares | Defined | 2025-08-11 | |
| 2024-03-31 | $413,811 | 53,672 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $423,024 | 47,055 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $495,043 | 55,374 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $842,388 | 54,843 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,082,038 | 48,112 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $914,805 | 43,500 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $860,256 | 34,913 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $912,962 | 37,679 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,681,621 | 65,255 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,199,308 | 70,854 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,804,466 | 74,411 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,161,728 | 79,625 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,721,105 | 108,975 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $2,507,787 | 92,012 | Shares | Defined | 2021-02-03 | |
| No filing history on record for this holder in this stock. | ||||||